Banka Bioloo Ltd
Incorporated in 2012, Banka Bioloo Ltd does manufacturing, supply, installation and O&M
of Bio toilets and Controlled discharge toilet system[1]
- Market Cap ₹ 65.6 Cr.
- Current Price ₹ 60.0
- High / Low ₹ 97.9 / 57.0
- Stock P/E
- Book Value ₹ 29.2
- Dividend Yield 0.00 %
- ROCE 0.87 %
- ROE -5.72 %
- Face Value ₹ 10.0
Pros
- Company's working capital requirements have reduced from 127 days to 70.8 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 2.82% over past five years.
- Company has a low return on equity of 1.11% over last 3 years.
- Company has high debtors of 170 days.
- Promoter holding has decreased over last 3 years: -3.16%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.19 | 14.27 | 15.12 | 16.53 | 35.42 | 47.86 | 30.46 | 38.63 | 42.15 | 49.97 | 55.00 | 55.82 | |
| 7.72 | 13.22 | 10.63 | 13.12 | 29.19 | 39.26 | 27.01 | 33.10 | 35.89 | 46.55 | 53.05 | 56.02 | |
| Operating Profit | 0.47 | 1.05 | 4.49 | 3.41 | 6.23 | 8.60 | 3.45 | 5.53 | 6.26 | 3.42 | 1.95 | -0.20 |
| OPM % | 5.74% | 7.36% | 29.70% | 20.63% | 17.59% | 17.97% | 11.33% | 14.32% | 14.85% | 6.84% | 3.55% | -0.36% |
| 0.01 | 0.06 | 0.04 | 0.16 | 0.37 | 0.45 | 0.58 | 0.45 | 0.81 | 0.77 | -6.80 | 1.07 | |
| Interest | 0.23 | 0.46 | 0.07 | 0.80 | 0.62 | 0.96 | 1.56 | 1.78 | 1.49 | 2.05 | 2.72 | 2.58 |
| Depreciation | 0.13 | 0.16 | 2.77 | 0.19 | 0.32 | 0.47 | 0.60 | 0.94 | 1.43 | 1.72 | 1.82 | 1.85 |
| Profit before tax | 0.12 | 0.49 | 1.69 | 2.58 | 5.66 | 7.62 | 1.87 | 3.26 | 4.15 | 0.42 | -9.39 | -3.56 |
| Tax % | 41.67% | 36.73% | 38.46% | 26.36% | 20.49% | 20.73% | -17.65% | 6.13% | 25.78% | 21.43% | -1.06% | |
| 0.08 | 0.32 | 1.04 | 1.89 | 4.51 | 6.05 | 2.21 | 3.06 | 3.08 | 0.33 | -9.30 | -2.91 | |
| EPS in Rs | 2.67 | 10.67 | 34.67 | 1.83 | 4.38 | 5.87 | 2.15 | 2.82 | 2.84 | 0.30 | -8.55 | -2.67 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 9.11% | 6.79% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 3% |
| 3 Years: | 13% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -480% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -5% |
| 3 Years: | -10% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 4% |
| 3 Years: | 1% |
| Last Year: | -6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.13 | 0.13 | 0.13 | 4.11 | 4.11 | 4.11 | 10.28 | 10.85 | 10.85 | 10.85 | 10.87 | 10.88 |
| Reserves | 2.37 | 2.69 | 3.81 | 13.73 | 17.74 | 23.78 | 19.75 | 26.61 | 29.74 | 30.35 | 21.73 | 20.95 |
| 1.89 | 3.90 | 4.45 | 4.27 | 2.14 | 11.59 | 11.69 | 16.08 | 15.21 | 20.23 | 24.95 | 23.19 | |
| 1.40 | 2.85 | 2.66 | 1.64 | 4.29 | 7.30 | 4.65 | 6.05 | 6.77 | 9.34 | 13.74 | 14.83 | |
| Total Liabilities | 5.79 | 9.57 | 11.05 | 23.75 | 28.28 | 46.78 | 46.37 | 59.59 | 62.57 | 70.77 | 71.29 | 69.85 |
| 1.50 | 1.43 | 1.45 | 1.75 | 2.77 | 4.02 | 5.09 | 6.17 | 10.13 | 10.66 | 9.81 | 17.05 | |
| CWIP | 0.13 | 0.14 | 0.19 | 0.00 | 0.34 | 0.00 | 0.00 | 2.42 | 0.69 | 6.51 | 7.64 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 4.36 | 5.36 | 5.34 | 0.98 | 0.98 |
| 4.16 | 8.00 | 9.41 | 22.00 | 25.17 | 42.76 | 41.25 | 46.64 | 46.39 | 48.26 | 52.86 | 51.82 | |
| Total Assets | 5.79 | 9.57 | 11.05 | 23.75 | 28.28 | 46.78 | 46.37 | 59.59 | 62.57 | 70.77 | 71.29 | 69.85 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.41 | -0.60 | 0.43 | -2.83 | -0.97 | -6.00 | 5.83 | -0.96 | 4.23 | 5.32 | 0.71 | |
| -0.71 | -0.07 | -0.20 | -5.42 | -3.47 | -5.06 | -4.71 | -10.92 | -5.39 | -8.89 | -3.02 | |
| 2.18 | 0.68 | 0.12 | 10.53 | -3.03 | 7.59 | -3.65 | 1.36 | -2.21 | 3.01 | 2.05 | |
| Net Cash Flow | 0.07 | 0.02 | 0.35 | 2.27 | -7.47 | -3.47 | -2.53 | -10.51 | -3.36 | -0.56 | -0.26 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66.85 | 146.56 | 162.46 | 204.47 | 100.06 | 114.17 | 139.96 | 164.22 | 190.42 | 143.09 | 170.42 |
| Inventory Days | 139.56 | 59.76 | 45.25 | 101.47 | 105.03 | 356.99 | |||||
| Days Payable | 85.17 | 106.19 | 94.67 | 80.33 | 52.08 | 192.18 | |||||
| Cash Conversion Cycle | 121.24 | 100.13 | 113.04 | 225.61 | 153.01 | 114.17 | 139.96 | 164.22 | 190.42 | 307.91 | 170.42 |
| Working Capital Days | 103.39 | 64.71 | 101.39 | 187.69 | 114.69 | 147.95 | 243.73 | 200.03 | 168.69 | 140.39 | 70.81 |
| ROCE % | 17.10% | 23.30% | 22.16% | 27.25% | 27.04% | 8.45% | 10.58% | 10.32% | 4.21% | 0.87% |
Documents
Announcements
-
Copy of Newspaper Publication
13 February 2026 - Published unaudited standalone and consolidated results for quarter and nine months ended 31 Dec 2025.
-
Investor Presentation
12 February 2026 - Investor presentation Q3 ended 31 Dec 2025: Revenue Rs15.93cr; EBITDA positive; PAT loss Rs0.22cr; Orderbook Rs113cr
-
Outcome of Board Meeting
12 February 2026 - Board approved unaudited standalone and consolidated results for quarter/nine months ended 31 Dec 2025.
-
Outcome of Board Meeting
12 February 2026 - Board approved unaudited standalone and consolidated results for quarter and nine months ended 31 Dec 2025; limited review reports.
-
Updates
22 January 2026 - NSE approved listing of 29,575 ESOP equity shares, trading from 23 January 2026.
Annual reports
Concalls
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
Business Overview:[1][2]
Company develops water, sanitation, and hygiene infrastructure and services in India. It provides sanitation infrastructure and turnkey, human waste management solutions and services. Company partners with governments, non-profit organizations, businesses, and communities to implement sustainable WaSH projects in unserved and underserved areas. It constructs waste water treatment and conservation plants, installing sanitation facilities for bio waste management, and develops reliable water supply systems